Bardy Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Bardy Diagnostics's estimated annual revenue is currently $54M per year.
- Bardy Diagnostics received $Undisclosed in venture funding in July 2018.
- Bardy Diagnostics's estimated revenue per employee is $313,750
- Bardy Diagnostics's total funding is $35.5M.
Employee Data
- Bardy Diagnostics has 172 Employees.
- Bardy Diagnostics grew their employee count by 11% last year.
Bardy Diagnostics's People
Name | Title | Email/Phone |
---|---|---|
1 | vp Sales | Reveal Email/Phone |
2 | VP Operations | Reveal Email/Phone |
3 | Director, Mentor Program | Reveal Email/Phone |
4 | Clinical Service Manager | Reveal Email/Phone |
5 | Account Executive | Reveal Email/Phone |
6 | Account Executive | Reveal Email/Phone |
7 | Account Executive | Reveal Email/Phone |
8 | Account Executive | Reveal Email/Phone |
9 | Account Executive | Reveal Email/Phone |
10 | cardiac analysis technician | Reveal Email/Phone |
Bardy Diagnostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.9M | 39 | 117% | $14.9M | N/A |
#2 | $44.9M | 143 | -30% | $211.3M | N/A |
#3 | $54M | 172 | 11% | $35.5M | N/A |
#4 | $4.3M | 17 | -19% | N/A | N/A |
#5 | $18.3M | 73 | N/A | N/A | N/A |
#6 | $8.3M | 33 | 6% | N/A | N/A |
#7 | $81.1M | 323 | 17% | N/A | N/A |
#8 | $7M | 28 | -12% | N/A | N/A |
#9 | $204.8M | 816 | 3% | N/A | N/A |
#10 | $6.3M | 50 | 25% | $27.5M | N/A |
What Is Bardy Diagnostics?
Bardy Diagnostics, Inc. (bardydx.com) has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Bardy Dx was founded to address the long-standing complaint in cardiac arrhythmia monitoring that traditional monitors were large, bulky, uncomfortable, and typically recorded noisy QRS signals. Our goal: to completely redesign an arrhythmia monitor with optimal signal detection, comfort, and ease of use. CAM is the first P-wave centric ECG monitor - a single-patient use monitor that records continuously for up to 7 days. This focus on the P-wave is a major new tool for cardiologists and cardiac rhythm specialists for accurately diagnosing arrhythmias.
keywords:N/A$35.5M
Total Funding
172
Number of Employees
$54M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bardy Diagnostics News
... Hill-Rom services iRhythm Technologies AliveCor Cardiac Insight Inc., VitalConnect, LifeSignals Bardy Diagnostics Nasiff Associates,...
Bardy Diagnostics Cardiomo Cardiologs Dragerwerk AG Hoffmann-La Roche GE Healthcare GrandCare Masimo Corporation Medopad
Dr. Gust Bardy, founder of Bardy Diagnostics. (Bardy Photo) Hillrom, a publicly-traded medical device and digital health company based in Chicago, will pay $375 million to acquire Seattle startup Bardy Diagnostics. Founded in 2013, Bardy set out to change the way medical professionals monitor ...
The clearance was received by Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data ...
SEATTLE, Sept. 6, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc. Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $25.9M | 172 | -12% | $50.9M |
#2 | $43.1M | 172 | 5% | N/A |
#3 | $27.6M | 173 | 4% | N/A |
#4 | $42.1M | 174 | 31% | N/A |
#5 | $26.2M | 174 | -41% | $247.3M |
Bardy Diagnostics Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2017-01-06 | $Undisclosed | Undisclosed | Multiple | Article |
2018-07-19 | $Undisclosed | Undisclosed | SV Health Investors | Article |